STO:ODI
ODI Pharma AB · STO · Healthcare · SEK · FY for 2026
Figures on this page computed 2026-11-08 13:20 UTC
Last close
n/aSEK
Market data
14.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
Safety is the furthest below its sector's middle: 0.46 against 0.63 on the market's range.
- Growth133.8%89 of 100, above its sector
- Returns on capital83.7%99 of 100, above its sector
- Margins31.2%60 of 100, above its sector
- Price14.4x47 of 100, above its sector
- Safety1.8146 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Sales
10,518Shares in issue
120- Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.
Sales is at 10518, Shares in issue is at 120, against 100 in 2019.
Sales is at 10518, Shares in issue is at 120, against 100 in 2019.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales, where the first year is 10010,518
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Profit, where the first year is 100n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Shares in issue, where the first year is 100120
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK